Demyelination occurring during anti-TNF alpha therapy – (02-18-02)

Demyelination occurring during anti-TNF alpha therapy

With the increasing use of TNF-alpha blockade I am sure we are going to see an increase in the side effects; some of which may be unforeseen and dangerous. When you begin to mess with one of the fundamental cytokines for inflammation we can not even begin to imagine the downstream effects. Natural routes of TNF-alpha reduction would include weight loss, lowering of hyperinsulinemia, antioxidant therapy, and possibly the reduction of LPS (antigenic compounds from bad bacteria) via restoration of a healthy GI environment.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.